By Anne Blythe United Methodist clergy have been put through their paces in recent years, with the COVID-19 pandemic and a highly publicized schism over LGBTQ+ inclusion that led to 7,600 …
TONGXIANG, CHINA – Media OutReach Newswire – 6 November 2026 – A robot makes coffee. Others dance, patrol exhibition halls or trade mock blows in choreographed demonstrations. Scenes like these …
How Can Payers Fit Into the Consumer Health Era?
During a panel at MedCity INVEST Digital Health, healthcare experts discussed the role of payers in the new consumer-driven healthcare era. The post How Can Payers Fit Into the Consumer Health …
Do We Have a Choice But to Ensure the Success of VBC? Part 1
In part 1, we delve into how physicians are looking at value-based care. It involves a visit to a local The post Do We Have a Choice But to Ensure the Success of VBC? Part 1 appeared first on …
Why the Wealth of Data From Wearables Are Important for Consumers and Clinicians
Growing use of wearable technologies and the data they produce was discussed by a panel at the MedCity News INVEST Digital Health Conference in Dallas. The post Why the Wealth of Data From …
TechMediaBreaks – Silynxcom Ltd. (NYSE American: SYNX) Develops AI-Powered Wearable Drone Detection System for Growing Defense Market
Silynxcom (NYSE American: SYNX) is expanding into the counter-drone defense market with the development of an AI-powered wearable detection and early-warning system designed to protect individual …
TechMediaBreaks – SS Innovations International Inc. (NASDAQ: SSII) Advances Telerobotic Surgery with 195 Remote Procedures Across Global Markets
SS Innovations International (NASDAQ: SSII) is strengthening its position in the emerging telerobotic surgery market as advances in surgical robotics and communications technology create new …
(BookTrib) - “The Final Second” by Jim De La VegaExecuting a serial killer ought to close the case for good. But just after Eddie Ray Calhoone is put to death, Sheriff Parker Chord receives a …
(NewsUSA) - You have car insurance, pay your premiums and assume you're protected if an accident happens. But what if the coverage you rely on isn't enough to pay for a serious injury?For many …
(NewsUSA) - Santa has elves. You have ChatGPT. But is your new chatbot on the naughty or nice list? Before putting artificial intelligence in charge of your gift list, shoppers should understand when …
(NewsUSA) - Before contacting a company, a potential customer may have a question: What should I look for in a contractor? How do I compare service providers? Which businesses can help solve my …
(BookTrib) - “Birth-Rate Crisis: Reclaiming Family and Purpose in a Dopamine-Driven World” by Jim Penman and Andrea PearsonHousing costs. Career pressures. Finding the right partner. The …
(NewsUSA) - A flying rock, an unexpected crack, and suddenly your windshield becomes another thing on your to-do list. But while windshield damage can happen in an instant, getting it fixed doesn't …

BioMedNewsBreaks – Earth Science Tech Inc. (ETST) Builds Long-Term Value Through Strategic Integration

Earth Science Tech (OTCQB: ETST), a diversified holding company operating across healthcare, pharmacy, technology, telemedicine, real estate, and consumer products, is leveraging synergies among its …

BioMedNewsBreaks – Why Adaptogenics Health Corp. (CSE: ADPT) Is ‘One to Watch’

Disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. Adaptogenics (CSE: ADPT) was featured in a recent article that discussed its efforts to build a healthcare …

ChineseNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) andGenius Group (NYSE American: GNS) Sign Joint Venture Agreement for 100 MW Alberta Data Center Program

FingerMotion (NASDAQ: FNGR) together with Genius Group Limited (NYSE American: GNS) and BlueFlare Energy Solutions Inc., announced a second binding agreement establishing a joint venture for the …

BioMedNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Prices $21 Million Public Offering to Support Buntanetap Clinical Development 

Annovis Bio (NYSE: ANVS), a Phase 3 clinical-stage biotechnology company, announced the pricing of an underwritten public offering of 19 million common shares, pre-funded warrants to purchase up to 2 …
More health news